2583.30 -77.75 (-2.92%)
2,938 NSE+BSE Volume
NSE May 24, 2022 03:31 PM
There were no Insider Trade disclosures made for AstraZeneca Pharma India Ltd.
The latest disclosures under SEBI SAST(Substantial Acquisition of Shares and Takeovers) Regulations, 2011 transaction was made by Tejas B Trivedi in AstraZeneca Pharma India Ltd. where Acquisition of 18,478 shares done was reported to the exchange on March 20, 2020.
Insider trades are disclosures under SEBI (Prohibition of Insider Trading) Regulations, 2015 ([Regulation 7 (2) with 6(2)] made by corporate insiders: promoters, officers, directors, employees and large shareholders who are buying and selling stock in their own companies.
| Client Name | Client Category | Action* | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Period | Regulation (Insider/SAST) | Security Type | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Tejas B Trivedi | Other | Acquisition | 20 Mar 2020 | 18,478 | 1,260,138 (5.04%) | 0.07 % | 20 Mar 2020 20 Mar 2020 |
SAST (29(1)) | - | Market | |
| ICICI Prudential Asset Management Company Ltd | Other | Disposal | 16 Jan 2019 | 115,578 | 892,519 (3.11%) | 0.46 % | 15 Jan 2019 15 Jan 2019 |
SAST (29(2)) | - | Market | |
| ICICI Prudential Asset Management Company Ltd (Revised) | Other | Disposal | 16 Jan 2019 | 115,578 | 776,941 (3.11%) | 0.46 % | 15 Jan 2019 15 Jan 2019 |
SAST (29(2)) | - | Market | |
| ICICI Prudential Mutual Fund | Other | Acquisition | 07 Sep 2015 | 198,836 | - | 0.80 % | 03 Sep 2015 03 Sep 2015 |
SAST (29(1)) | - | Market |
Compare Stocks
